accountLaboratory equipment company Thermo Fisher Scientific Inc (TMO.N) agreed to acquire private-equity owned Phadia, maker of allergy and autoimmune tests, for about $3.5 billion to expand in specialty diagnostics. Thermo said on...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Thermo Fisher to buy Phadia for $3.5 billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account